Navigation Links
Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
Date:3/12/2009

phoblastic leukemia.
  • In September, Micromet presented the first clinical data from a phase 1b clinical trial studying the combination of adecatumumab with docetaxel in late stage metastatic breast cancer patients at the European Society for Medical Oncology in Stockholm, Sweden.
  • In August, Micromet presented the first peer-reviewed publication of clinical data on blinatumomab from the phase 1 clinical study in relapsed non-Hodgkin's lymphoma patients. These data were published in the journal Science (321: 974-977 (2008)).
  • In April, Micromet presented the first pre-clinical data on new BiTE antibodies targeting EGFR, HER-2, MCSP and CD33. In addition, data was presented from animal studies testing the subcutaneous delivery of blinatumomab and MT110.
  • Financings and related Events in 2008:

    • In December, Micromet entered into a new committed equity financing facility with Kingsbridge Capital Limited, replacing a similar facility that was established in 2006. Under the renewed facility, Kingsbridge has committed to purchase, subject to certain restrictions, limitations and conditions, up to $75 million of common stock at the time and in the amounts deemed suitable to Micromet, until December 1, 2011. Micromet is not obligated to sell to Kingsbridge any of the $75 million of common stock available under the facility, and there are no minimum commitments or minimum use penalties.
    • In November, Micromet was added to the NASDAQ Biotechnology Index.
    • In October, Micromet closed a sale of its common stock in a private placement transaction that yielded $40 million in gross proceeds.

    Program Updates in 2009:

    Consistent with its January 5, 2009, press release titled "Micromet Key Events for 2009," Micromet intends to provide an update on its research
    '/>"/>

    SOURCE Micromet, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related biology technology :

    1. Micromet, Inc. Reports Third Quarter 2008 Financial Results
    2. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
    3. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
    4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
    5. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
    6. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
    7. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
    8. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
    9. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
    10. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
    11. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... 27, 2015 In response to recent ... and The US Postal Service to no longer ... ,select agents, by the CDC, Marken reaffirmed today ... sensitive shipments. Marken uses its flexible ... and certified personnel to ensure the safe and ...
    (Date:8/26/2015)... MO (PRWEB) , ... August 26, 2015 , ... ... it is increasing its investment in the development and manufacture of highly valued ... The company’s scientific team's extensive expertise with protein chemistry has led to ...
    (Date:8/26/2015)... Aug. 26, 2015 China Cord Blood Corporation ... leading provider of cord blood collection, laboratory ... services, today announced that the Company has been informed ... entity wholly owned by Mr. Yuen Kam, chairman of ... the outstanding shares (the "Shares") of  Excellent China Healthcare ...
    (Date:8/25/2015)... 2015   WuXi PharmaTech (Cayman) Inc. (NYSE: ... platform company serving the pharmaceutical, biotechnology, and medical device ... Kong Exchange Stock Code: 0950), a research-based biopharmaceutical company ... 20 years of operations in China ... an agreement whereby WuXi,s Laboratory Testing Division (LTD) will ...
    Breaking Biology Technology:Marken Ensures Safe Transportation Of Select Agents And Toxins 2Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3
    ... has announced that the southwestern laboratory network TriCore ... Virus genotyping reagents. , ,The reagents are part of tests ... virus, a blood-transmitted disease estimated to be chronic in 4 ... do not know it, according to Third Wave's company statement. ...
    ... Every year around Labor Day, a slew of surveys and ... worker. One released by the Associated Press earlier this week ... percent) and think their pay is fair (71 percenet). But ... ,In the spirit of the presidential election season, I thought ...
    ... James Thomson, pictured here in 2001 in his Primate Center ... of Wisconsin anatomy professor James Thomson attempted to ... of stem cell research, which in some cases uses tissue ... to about 200 at the UW Memorial Union as part ...
    Cached Biology Technology:Are your working conditions better now or worse? 2Are your working conditions better now or worse? 3UW stem cell guru outlines scientific and political future 2UW stem cell guru outlines scientific and political future 3
    (Date:8/17/2015)... 2015  NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... Q4 2015. The new marketing campaign is being spearheaded ... Marketing Group ( http://amplitudemarketing.com/ ) and TPMG ( http://tmpg.com/ ... in retail driven marketing and brand awareness and has ...
    (Date:8/12/2015)... JOSE, Calif. , Aug. 12, 2015 /PRNewswire/ ... developer of human interface solutions, today announced that ... recently announced Match-in-Sensor solution, have officially been named ... Alliance. As part of the certification, Synaptics, Natural ... FIDO 1.0 Universal Authentication Framework (UAF) standard and ...
    (Date:8/6/2015)... , Aug. 6, 2015  Today, U.S. ... visit Crossmatch ™ to learn firsthand how ... protect data. Crossmatch is a world leader in ... and expertise are helping federal agencies and commercial ... security.   "The vast majority of ...
    Breaking Biology News(10 mins):NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 2NXT-ID, Inc. Launches Sales Campaign for Wocket Smart Wallet with Award Winning Marketing Team 3Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3Rep. Honda to Visit Crossmatch in Redwood City 2
    ... a little genetics in high school has heard of adenine, ... make up the DNA code. But those are not the ... has drawn attention to a fifth nucleotide, 5-methylcytosine (5-mC), that ... regulate which genes are expressed. And now there,s a sixth. ...
    ... chromosome it,s time X got some attention. ... with being female, University of California, Berkeley, biologist Doris ... the X chromosome is every bit as interesting as ... to the origins and benefits of sexual reproduction. ...
    ... its kind study examining the effects of methamphetamine use during ... development in children. The research is published in the April ... journal of the American Academy of Neurology. ... age, leading to an increasing number of children with prenatal ...
    Cached Biology News:New nucleotide could revolutionize epigenetics 2New nucleotide could revolutionize epigenetics 3New nucleotide could revolutionize epigenetics 4The story of X -- evolution of a sex chromosome 2The story of X -- evolution of a sex chromosome 3The story of X -- evolution of a sex chromosome 4Prenatal meth exposure linked to abnormal brain development 2
    Borosilicate Glass. Certified for use with the Beacon 2000 Systems, 1,000 tubes/case...
    ...
    ... Immunogen : Recombinant human HMGN2/HMG-17 ... BSA, 0.15M NaCl, 0.05% sodium ... glycerol to 30% Quality Assurance: ... acid extracts of murine 10T ...
    ...
    Biology Products: